ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-34.86M | $-32.26M | $205.40M | $-149.68M | $-192.73M | $-183.94M | $-156.32M | $-95.21M | $-45.99M |
| Capital expenditures | $2.51M | $6.32M | $11.20M | $18.80M | $61.75M | $16.35M | $10.70M | $3.66M | $2.96M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $7.01M | $11.15M | $13.12M | $24.76M | $43.25M | $55.48M | $62.91M | $53.61M | $51.48M |
| Free cash flow | $-37.36M | $-38.58M | $194.20M | $-168.49M | $-254.47M | $-200.29M | $-167.02M | $-98.88M | $-48.95M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $26.86M | $15.63M | $-48.77M | — | — | — |